GlassScriptPhysician profile
Bijay Pandey
NPI 1942417738
$3,705.22
in general payments reported to CMS, 2019-2025
43 companies · $517 in 2025
The $517 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $990 · 2021: $280 · 2022: $778 · 2023: $391 · 2024: $609 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,499 · Education: $17.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,499.21 |
| Education | $17.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,077.36 | 2020-2025 | Rystiggo, Briviact |
| Horizon Therapeutics Plc | $252.30 | 2022-2023 | Uplizna |
| Neurelis, INC. | $189.05 | 2023-2025 | Valtoco |
| Teva Pharmaceuticals USA, INC. | $185.07 | 2019-2025 | Austedo Xr, Austedo Xr |
| Abbvie INC. | $130.04 | 2021-2023 | |
| Alexion Pharmaceuticals, INC. | $127.74 | 2019-2025 | Ultomiris, Soliris |
| Biogen, INC. | $124.68 | 2021-2025 | Leqembi, Vumerity, Avonex |
| Pfizer INC. | $120.52 | 2023-2025 | |
| Lilly USA, LLC | $113.86 | 2022-2024 | Amyvid |
| Sk Life Science, INC. | $110.15 | 2021-2024 | |
| Upsher-Smith Laboratories LLC | $97.83 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $94.05 | 2022-2025 | |
| Argenx US, INC. | $78.46 | 2023-2025 | Vyvgart, Vyvgart Hytrulo |
| Amgen INC. | $74.35 | 2021-2025 | Uplizna |
| Genzyme Corporation | $73.77 | 2021-2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bijay Pandey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.